Profile
GMVD ISRG BDX ALC RMD WST
Company Name G Medical Innovations Holdings Ltd Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. ResMed Inc. West Pharmaceutical Services, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $1.80M $156.82B $68.58B $46.06B $28.95B $20.74B
Employees 0.08K 13.68K 70.00K 25.00K 10.14K 10.60K
CEO Dr. Yacov Geva Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM Mr. Eric M. Green
Ratings
GMVD ISRG BDX ALC RMD WST
Quant Rating Score 3 3 3 3 3
Quant Rating Neutral Neutral Neutral Neutral Neutral
Trading
GMVD ISRG BDX ALC RMD WST
Last Close $0.1835 $441.3 $237.3 $93.37 $197.04 $284.76
High 52 $0.34 $461.12 $283.59 $93.36 $225.35 $413
Low 52 $0.16 $258.49 $221.47 $69.56 $134.65 $277.16
Price vs. 52 Week High -46.03 % -4.3 % -16.32 % 0.01 % -12.56 % -31.05 %
Price vs. 52 Week Low 14.69 % 70.72 % 7.15 % 34.23 % 46.33 % 2.74 %
Total Return
GMVD ISRG BDX ALC RMD WST
1 Month Return 0 % -0.86 % 2.75 % 4.08 % 2.85 % -13.38 %
3 Month Return 0 % 17.58 % 2.48 % 18.53 % -9.64 % -20.99 %
6 Month Return 0 % 17.76 % 0.27 % 22.86 % 3.62 % -21.2 %
9 Month Return 0 % 70.4 % -5.68 % 33.37 % 46.33 % -11.27 %
YTD Return 0 % 30.81 % -2.68 % 19.52 % 14.54 % -19.13 %
1 Year Return -46.19 % 36.39 % -16.32 % 10.11 % -11.04 % -19.76 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
GMVD ISRG BDX ALC RMD WST
Dividend Yield Percentage (TTM) - - 1.58 % 0.28 % 0.97 % 0.21 %
Dividend Paid and Capex Coverage Ration (TTM) -8.71 % 1.16 % 2.05 % 1.66 % 2.97 % 1.66 %
Dividend Per Share (TTM) - - 3.76 % 0.26 % 1.92 % 0.6 %
Payout Ratio (TTM) - - 82.6 % 11.25 % 28.85 % 11.07 %
Growth
GMVD ISRG BDX ALC RMD WST
Asset Growth -54.12 % 19.02 % -0.29 % 1.35 % 32.49 % 5.88 %
Gross Profit Growth -47.8 % 12.71 % -3.62 % 18.11 % 16.37 % -0.62 %
Revenue Growth -12.61 % 14.49 % 2.66 % 15.77 % 18.02 % 2.18 %
Revenue 3 Year -100 % 63.36 % 10.28 % 46.5 % 40.45 % 36.66 %
Revenue 5 Year -100 % 85.79 % 9.38 % 39.86 % 75.54 % 70.83 %
Revenue 10 Year - 223.26 % 63.97 % 53.48 % 171.6 % 101.93 %
EBIT Growth -173.09 % 45.86 % -7.49 % 87.58 % 13.15 % -7.9 %
Net Income Growth 6.25 % 35.98 % -16.58 % 190.75 % 15.15 % 1.28 %
Net Income 3 Yeari Growth Per Share 100 % 69.43 % 65.46 % 281.94 % 41.99 % 70.48 %
Net Income 5 Yeari Growth Per Share 100 % 54.83 % 330.62 % 525.33 % 176.65 % 185.26 %
Net Income 10 Yeari Growth Per Share - 175.41 % -21.76 % 225.89 % 184.65 % 394.98 %
Operating Income Growth -173.09 % 45.86 % -7.49 % 87.58 % 13.15 % -7.9 %
Operating Cash Flow Growth (CFG) -60.77 % 21.67 % 13.52 % 21.73 % 97.44 % 7.25 %
Operating 3 Year CFG - 22.09 % -17.7 % 78.55 % -15.01 % 63.45 %
Operating 5 Year CFG - 50.62 % -5.85 % 28.82 % 33.54 % 167.61 %
Operating 10 Year CFG - 111.85 % 35.21 % 11.44 % 67.64 % 229.88 %
EPS Growth 100 % 37.63 % -16.19 % 201.43 % 14.61 % 1.4 %
EPS Diluted Growth 100 % 37.81 % -15.99 % 198.57 % 14.91 % 1.94 %
Book Value Per Share 100 % 21.29 % 1.5 % 4.44 % 22.3 % 7.45 %
Share Holder 3 Year Equity Growth Per Share 100 % 36.28 % 5.73 % 8.65 % 62.66 % 54.52 %
Share Holder 5 Year Equity Growth Per Share -100 % 93.27 % 10.89 % -9.73 % 95.11 % 105.22 %
Share Holder 10 Year Equity Growth Per Share -100 % 290.63 % 248.77 % -13.54 % 149.77 % 197.74 %
Dividend Per Share Growth - - 2.5 % 15.62 % 4.77 % 5.5 %
Dividend 3 Year Growth Per Share - - 5.8 % - 12.84 % 17.87 %
Dividend 5 Year Growth Per Share - - 8.45 % - 25.93 % 34.66 %
Dividend 10 Year Growth Per Share - - 96.74 % - 158.81 % 99.23 %
Debt Growth -73.32 % -4.26 % -1.16 % 1.48 % 72.19 % -2.8 %
Free Cash Flow Growth -71.04 % -21.79 % 27.41 % 21.44 % 186.66 % -5.67 %
Updated On 31 Dec 2022 31 Dec 2023 30 Sep 2023 31 Dec 2023 30 Jun 2023 31 Dec 2023
Profitability
GMVD ISRG BDX ALC RMD WST
Gross Profit Margin TTM 17.74 % 66.86 % 41.25 % 55.6 % 57.28 % 35.73 %
Return on Assets TTM -289.28 % 12.57 % 2.46 % 3.54 % 14.06 % 15.04 %
Return on Equity TTM 208.58 % 15.36 % 5.19 % 5.14 % 21.92 % 19.08 %
Return on Capital Employed TTM 639.23 % 12.88 % 4.64 % 5.08 % 20.09 % 20.72 %
Net Income Per EBT TTM 100.11 % 93.85 % 81.08 % 108.82 % 80.95 % 85.87 %
EBT Per Ebit TTM 50.86 % 114.25 % 75.69 % 69.52 % 97.52 % 103.3 %
EBIT Per Revenue TTM -620.14 % 25.79 % 11.02 % 14.3 % 27.31 % 20.57 %
Cash Flow To Debt Ratio TTM -883.32 % 1671.71 % 20.88 % 32.36 % 116.24 % 331.45 %
Receivables Turnover TTM 4.68 6.09 7.7 5.28 5.44 5.73
Payables Turnover TTM 0.78 12.91 2.38 5.26 10.7 8.73
Inventory Turnover TTM 12.45 1.81 3.59 1.85 2.29 4.41
Fixed Asset Turnover TTM 166.98 % 183.94 % 299.14 % 206.93 % 647.17 % 175.95 %
Asset Turnover TTM 91.61 % 45.48 % 36.41 % 32.77 % 65.23 % 82.44 %
Operating Cash Flow Per Share TTM - 4.05 12.99 3.33 8.16 10.31
Free Cash Flow Per Share TTM - 0.54 10.45 1.57 7.29 4.89
Cash Per Share TTM - 1340.06 % 1112.54 % 232.28 % 176.54 % 611.23 %
Operating Cash Flow Sales Ratio TTM -418.08 % 18.96 % 19.08 % 16.99 % 26.97 % 26.15 %
Free Cash Flow Operating Cash Flow Ratio TTM 111.48 % 13.43 % 80.46 % 47.02 % 89.38 % 47.46 %
Cash Flow Coverage Ratios TTM -883.32 % 1671.71 % 20.88 % 32.36 % 116.24 % 331.45 %
Price To Free Cash Flows Ratio TTM -0.09 812.95 22.66 59.52 27.02 58.09
Price To Operating Cash Flows Ratio TTM - 109.1 18.27 28.01 24.16 27.63
Price Cash Flow Ratio TTM - 109.1 18.27 28.01 24.16 27.63
Income Statement (TTM)
GMVD ISRG BDX ALC RMD WST
Revenue $0B $7.12B $19.37B $10.09B $4.22B $2.95B
Gross Profit $0B $4.73B $8.17B $5.61B $2.36B $1.13B
Gross Profit Ratio 17.74% 66.39% 42.17% 55.57% 55.78% 38.28%
EBITDA $-0.04B $2.19B $4.72B $2.56B $1.34B $0.88B
Net Income $-0.01B $1.8B $1.48B $0.97B $0.9B $0.59B
EPS Diluted - 5.03 4.94 2.09 6.09 7.88
Balance Sheet (MRQ)
GMVD ISRG BDX ALC RMD WST
Long Term Debt $0B $-0.08B $14.74B $4.59B $1.55B $0.16B
Total Liabilities $0.01B $2.04B $26.98B $8.99B $2.62B $0.95B
Total Equity $-0B $13.4B $25.8B $20.62B $4.13B $2.88B
Total Investments $0B $4.59B $0.01B $0.28B $-0.13B $0.21B
Total Debt $0B $0.09B $15.88B $5.14B $1.58B $0.31B
Total Assets $0B $15.44B $52.78B $29.6B $6.75B $3.83B
Cash Flow Statement (TTM)
GMVD ISRG BDX ALC RMD WST
Net Income $-0.03B $1.82B $1.53B $1.04B $0.9B $0.59B
Inventory $-0B $-0.71B $-0.02B $-0.29B $-0.25B $-0.01B
Dividends Paid $0B $0B $-1.11B $-0.12B $-0.26B $-0.06B
Operating Cash Flow $-0.02B $1.81B $2.99B $1.48B $0.69B $0.78B
Capital Expenditure $-0B $-1.06B $-0.87B $-0.91B $-0.13B $-0.36B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 2.46
ALC Alcon Inc. 93.37
ANGO AngioDynamics, Inc. 7.65
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 146.66
ATRC AtriCure, Inc. 22.1
ATRI Atrion Corporation 457.65
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 1.42
AZTA Azenta, Inc. 60.22
BAX Baxter International Inc. 35.51
BDX Becton, Dickinson and Company 237.3
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.81
BLFS BioLife Solutions, Inc. 24.04
COO The Cooper Companies, Inc. 93.21
DXR Daxor Corporation 9
EKSO Ekso Bionics Holdings, Inc. 1.3
FEMY Femasys Inc. 1.14
GCTK GlucoTrack, Inc. 1.36
Unlock